Steven Pergam

Professor

Fred Hutchinson Cancer Research Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Steven Pergam is a Professor at the Fred Hutchinson Cancer Center in the United States. His research focuses on infectious diseases, particularly in the context of hematopoietic cell transplantation, vaccine hesitancy, and the safety of immunocompromised patients during the COVID-19 pandemic. Recent articles by Professor Pergam delve into the ethical considerations of transplantation, predictive measures for sepsis, and the management of cytomegalovirus among transplant recipients.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Marian Michaels

Professor

University of Pittsburgh School of Medicine

UNITED STATES

View details

David C M Kong

MONASH UNIVERSITY

AUSTRALIA

View details

Erica J. Stohs

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Steven Pergam

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy

Advanced practice providers in the infectious disease workforce: A nationwide utilization survey

Cocooning against COVID‐19: The argument for vaccinating caregivers of patients with cancer

Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearance

Limits of the Glasgow Coma Scale When Assessing for Sepsis in Allogeneic Hematopoietic Cell Transplant Recipients.

Can a Simple Stool Swab Predict Bacteremia in High-Risk Hematopoietic Cell Transplant Recipients?

Outcomes of Hematopoietic Cell Transplantation in Patients with Mixed Response to Pretransplantation Treatment of Confirmed or Suspected Invasive Fungal Infection.

Care without a compass: including patients with cancer in COVID-19 studies.

Predictive Value of 3 Clinical Criteria for Sepsis (Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and National Early Warning Score) With Respect to Short-term Mortality in Allogeneic Hematopoietic Cell Transplant Recipients With Suspected Infections

Development and Validation of a Machine Learning Model to Estimate Bacterial Sepsis Among Immunocompromised Recipients of Stem Cell Transplant.

Collaborators (3)

Marian Michaels

David C M Kong

Erica J. Stohs

Make your next move.